A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM

Grant

Awarded By

Total Award Amount

  • 12000.00

    • Direct Costs

  • 6180.00

    • Sponsor Award Id

  • ABTC 1501

    • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Xiaosi Han   Investigator